Thermo Fisher Scientific (TMO) Payables (2009 - 2026)

Thermo Fisher Scientific has reported Payables for 18 years, with the latest figure at $3.3 billion in Q2 2026.

• Payables for Q2 2026 came in at $3.3 billion, up 9.66% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.3 billion (up 9.66% YoY), and the FY2025 annual result was $3.6 billion, up 17.64% from the prior year.
• Payables fell to $3.3 billion in Q2 2026, from $3.3 billion in the prior quarter.
• Over five years, Payables peaked at $3.6 billion in Q4 2025 and troughed at $2.4 billion in Q3 2023.
• A 5-year average of $2.9 billion and a median of $2.8 billion in 2023 frame the typical range for Payables.
• The widest annual swing landed in 2022, when Payables grew 24.28%; it then slipped 15.05% in 2023.
• A 5-year view of Payables shows it stood at $3.4 billion in 2022, then slipped by 15.05% to $2.9 billion in 2023, then climbed by 7.21% to $3.1 billion in 2024, then climbed by 17.64% to $3.6 billion in 2025, then fell by 9.77% to $3.3 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.3 billion in Q2 2026, $3.3 billion in Q1 2026, and $3.6 billion in Q4 2025.